Latest Observability News

Core Energy Minerals has confirmed uranium mineralisation at its Cummins Project in South Australia through a maiden aircore drilling program, reinforcing its geological model and setting the stage for targeted follow-up exploration.

CSL Limited has partnered with Dutch biotech VarmX to develop VMX-C001, a novel treatment aimed at reversing bleeding in patients on FXa inhibitors, with FDA Fast Track status and a potential 2029 launch.

Alterity Therapeutics has unveiled encouraging Phase 2 trial results for ATH434, demonstrating its potential to slow disease progression in Multiple System Atrophy while maintaining a strong safety profile.

Flynn Gold has initiated its first-ever diamond drilling program at the historically rich Double Event gold prospect in Northeast Tasmania, following trenching that revealed an extensive mineralised corridor. The drilling aims to validate and expand on promising surface assay results, potentially unlocking significant value for the Golden Ridge Project.

Altitude Minerals has secured drill permits and identified multiple high-priority copper-gold porphyry targets at its Byrock Project in NSW’s Macquarie Arc, with a 1,500m aircore and RC drill program planned for November 2025.

Kinetiko Energy has achieved a record peak gas flow from its latest production test well at Brakfontein, significantly surpassing previous results and advancing its pilot LNG project in South Africa.

Bubs Australia has appointed Paul Jensen as its new Independent Chair and Joe Coote as Managing Director and CEO, signaling a fresh leadership chapter for the infant formula and dairy company.

Actinogen Medical has reached a pivotal agreement with the US FDA outlining the regulatory and clinical trial requirements for Xanamem’s approval in Alzheimer’s disease, setting a clear path toward a US marketing application.

Washington H. Soul Pattinson and Brickworks have secured Supreme Court approval for their share schemes, marking a key milestone as Topco shares prepare to enter the ASX market.

EVE Health Group has appointed Dr Fiona Cousins as the inaugural member of its Scientific Advisory Board, reinforcing its commitment to advancing treatments for dysmenorrhoea and endometriosis ahead of the commercial launch of Dyspro™.

NH3 Clean Energy has signed a commitment agreement to lease land at the Port of Dampier, advancing its flagship WAH2 clean ammonia project with enhanced storage and export capabilities.

Altech Batteries has announced breakthrough performance milestones for its CERENERGY sodium nickel chloride battery technology, demonstrating exceptional cycle life, efficiency, and safety that position it as a strong contender in grid and industrial energy storage.